Category: Third-Party & Supply Chain

Vendor Oversight

Also known as: Third-Party Oversight, Vendor Management and Oversight, Supplier Oversight

Simply put

Vendor oversight is the practice of monitoring and governing outside companies (third parties) that an organization relies on, to keep track of the risks they may create for security, privacy, or day-to-day operations. In many settings it also involves reviewing a vendor's processes and managing the contractual relationship to reduce risk and protect the outcomes the organization is responsible for. It typically helps manage, rather than eliminate, the risks associated with using external providers.

Formal definition

Vendor oversight is a governance discipline for monitoring and controlling third parties whose activities can affect an organization's security, privacy, or operational risk. As commonly described, it encompasses activities such as review of vendor standard operating procedures and processes for the essential tasks performed on the organization's behalf, and management of contractual relationships to maximize value and minimize risk. It is frequently supported by technology used to centralize data and streamline monitoring. Note that vendor oversight sits within broader governance structures and, where AI models or services are procured from third parties, may overlap with model risk management activities; the evidence provided here does not specify AI-specific requirements, sector-specific regulatory obligations, or a single authoritative definition, and usage varies by context (for example, clinical trials versus financial services).

Why it matters

Organizations increasingly depend on third parties for critical functions, and the activities of those vendors can directly affect an organization's security, privacy, and operational risk. Because responsibility for outcomes typically remains with the organization even when work is performed by an outside provider, vendor oversight is a mechanism for keeping visibility into, and some measure of control over, risks that originate outside the organization's own walls. As commonly described, it helps manage rather than eliminate these risks.

The consequences of weak oversight vary by sector. In clinical trials, for example, proper oversight is described as critical to ensuring patient safety as well as mitigating the risks and financial implications of costly change orders and trial delays. In financial services and other contexts, vendor management is framed around overseeing contractual relationships to maximize value and minimize risk. The specific stakes therefore depend heavily on what the vendor does and the regulatory environment in which the organization operates.

Where AI models or services are procured from third parties, vendor oversight may overlap with model risk management, because an externally supplied model still introduces risks the organization must identify, monitor, and control. The evidence available here does not specify AI-specific requirements or a single authoritative definition, and usage varies by context, so the discipline should be scoped to the particular sector and risk profile rather than treated as a uniform, universally defined practice.

Who it's relevant to

Compliance and governance teams

Teams responsible for organizational governance use vendor oversight to maintain visibility into third parties that can affect security, privacy, or operational risk, and to situate that monitoring within broader governance structures. Responsibility for outcomes typically remains with the organization even where tasks are delegated to a vendor.

Model risk managers

Where AI models or services are procured from third parties, vendor oversight may overlap with model risk management activities. Practitioners should note that the evidence here does not specify AI-specific requirements, so any AI-related oversight expectations should be scoped to the applicable sector and framework rather than assumed.

Procurement and contract managers

Those managing supplier relationships apply vendor oversight to oversee and manage contractual relationships with the aim of maximizing value and minimizing risk, including through review of vendor processes for essential tasks performed on the organization's behalf.

Sector-specific practitioners (for example, clinical trials and financial services)

The meaning and stakes of vendor oversight vary by sector. In clinical trials, oversight is described as critical to patient safety and to mitigating risks such as costly change orders and trial delays, while in financial services it is often framed around contractual value and risk. Practitioners should apply the definition appropriate to their own regulatory context.

Inside Vendor Oversight

Vendor Due Diligence

The assessment performed before and during engagement with a third-party AI or model provider, typically covering the vendor's development practices, data provenance, security posture, and financial and operational stability. In many frameworks this is framed as a risk-tiered activity, with more intensive review applied to vendors supporting higher-risk or business-critical use cases.

Contractual and Service-Level Provisions

Terms that allocate responsibilities, define performance expectations, and establish rights such as audit access, documentation delivery, incident notification, and change management. These provisions are commonly the primary mechanism through which an organization retains oversight over a system it does not directly build.

Documentation and Transparency Access

The information an organization obtains from a vendor to understand and, where possible, independently evaluate a model, which may include intended use, limitations, training data descriptions, and testing results. Access is often constrained by the vendor's intellectual property and confidentiality protections, which is a recognized limitation for externally sourced models.

Ongoing Monitoring and Performance Review

The recurring activities used to track whether a vendor-supplied model continues to perform as expected in the deploying organization's environment, including monitoring for performance degradation over time. This is generally distinct from a one-time acceptance test and is a continuing obligation of the deploying organization.

Accountability and Ownership Assignment

The governance element clarifying that responsibility for outcomes typically remains with the deploying organization even when a model is externally developed. In many governance structures this involves designating an internal owner and aligning vendor oversight with defined lines of defense.

Concentration and Dependency Risk

Consideration of the exposure created when critical functions rely heavily on a single vendor or a small number of providers, including business continuity, exit, and substitutability considerations.

Common questions

Answers to the questions practitioners most commonly ask about Vendor Oversight.

Does using a third-party AI model transfer the associated risk and compliance responsibility to the vendor?

No. In most governance and model risk frameworks, the organization deploying a third-party model typically retains accountability for its use, outputs, and downstream impacts, even when development is outsourced. Vendor oversight is a mechanism to manage the risk arising from external dependencies, not a means to offload responsibility. Contractual allocation of liability may shift some obligations between parties, but this is generally distinct from the regulatory or supervisory accountability that stays with the deploying organization. Note that the precise allocation depends on jurisdiction, sector, and the specific arrangement.

Is vendor oversight simply a procurement or contract-management activity?

Not by itself. Procurement and contracting are components, but vendor oversight as commonly framed in model risk management extends across the full lifecycle: due diligence before onboarding, validation or independent review of vendor models where feasible, ongoing monitoring of performance and controls, and offboarding or contingency planning. Because vendors often limit access to proprietary details, oversight typically has to combine contractual terms with compensating controls such as outcome analysis and benchmarking, rather than relying on documentation alone.

How can an organization validate a vendor model when it cannot access the underlying code or training data?

Where full transparency is unavailable, oversight commonly relies on compensating approaches: requesting vendor validation documentation and methodology summaries, conducting outcome-based testing against the organization's own data, benchmarking against alternatives, sensitivity and stability analysis, and defining performance thresholds in the contract. It is worth distinguishing validation (assessing whether the model is conceptually sound and fit for the intended use) from verification (confirming it was implemented as specified); limited access may constrain the depth of each. Organizations should also document these limitations as part of the assessment.

What should ongoing monitoring of a vendor model typically cover?

Ongoing monitoring commonly addresses model performance over time (to detect performance degradation), stability of inputs and outputs, changes the vendor makes to the model or its updates, continued fit for the intended use case, and the vendor's own control environment and viability. Many programs distinguish monitoring model risk from monitoring model performance, since a stable-performing model can still present elevated risk from changing usage, data, or regulatory context. Escalation triggers and thresholds are usually defined in advance.

Where does vendor oversight sit within the lines-of-defense model?

In organizations using a three-lines structure, responsibilities are often distributed rather than owned by a single function. The first line (business or model owners) typically manages the vendor relationship and day-to-day controls; the second line (risk management or compliance) sets oversight standards and performs independent challenge; and the third line (internal audit) provides independent assurance over the process. The precise assignment varies by organization, and the distinction between these lines should be preserved rather than blurred, as each has a different role and independence expectation.

How should vendor concentration and dependency be addressed in an oversight program?

Programs commonly assess whether reliance on a single vendor, model, or upstream provider creates concentration risk, and whether contingency, exit, or substitution options exist. This may include documenting dependencies, evaluating switching feasibility and cost, and planning for vendor failure or discontinuation of a model. These measures are generally intended to reduce and manage the risk rather than eliminate it, and their appropriate scope tends to be proportionate to the criticality of the model and its use.

Common misconceptions

Purchasing a model from an established vendor transfers the associated model risk to that vendor.

Sourcing a model externally generally does not transfer accountability for its use. In many frameworks the deploying organization retains responsibility for outcomes, and vendor oversight is intended to manage rather than eliminate that risk. Contractual terms may allocate certain liabilities, but they typically do not remove the deploying organization's own governance and monitoring obligations.

Vendor oversight is complete once due diligence is performed and a contract is signed.

Initial due diligence and contracting are commonly treated as one phase of a continuing process. Ongoing monitoring for performance degradation, changes in the vendor's model, and evolving use is generally regarded as a distinct and continuing obligation rather than a one-time event.

A vendor's own documentation or self-attestation is a sufficient substitute for independent evaluation.

Vendor-supplied documentation supports understanding but is not always equivalent to independent assessment. Because intellectual property and confidentiality protections frequently limit access to a third-party model's internals, organizations often face constraints on independent evaluation, and this limitation should be acknowledged rather than assumed away.

Best practices

Apply a risk-tiered approach so that the depth of due diligence and ongoing monitoring scales with the criticality and risk of the vendor-supplied model's use case.

Negotiate contractual rights for documentation access, audit, incident and change notification, and performance expectations before deployment, recognizing that these terms are often the main lever for retaining oversight over externally built systems.

Assign a clear internal owner accountable for the vendor model's use, and align that ownership with your organization's defined lines of defense rather than treating the vendor as the accountable party.

Establish continuing monitoring for performance degradation and for vendor-initiated changes to the model, and document expected review frequency instead of relying on one-time acceptance testing.

Record and disclose the limits of your independent evaluation where vendor intellectual property or confidentiality restricts visibility, so that decision-makers understand the residual uncertainty.

Assess concentration and dependency risk, and maintain exit and business-continuity considerations for critical vendors so that oversight accounts for substitutability, not only day-to-day performance.